Background
==========

Tick-borne encephalitis (TBE) is caused by TBE virus (TBEV). The virus is transmitted to susceptible individuals through tick bites or consumption of unpasteurized milk from recently infected animals \[[@B1]\]. TBE is restricted to geographical areas referred to as endemic foci \[[@B1],[@B2]\]. Factors influencing survival of ticks, large mammals and transmission-competent rodents may explain the distribution of these foci and their changes over time \[[@B3],[@B4]\]. Symptoms of TBE do not differ from other infections of the central nervous system (CNS). Thus laboratory confirmation of each suspected case is necessary. Due to their immature CNS, young children experience less severe symptoms than adults \[[@B1]\]. Compared with other age groups, the elderly present atypical symptoms and suffer from severe outcomes and higher case-fatality \[[@B1],[@B5]\]. One third of infected adults develop flu-like symptoms. Of these, one third progresses to meningo-encephalitis following a 7-day symptom-free interval \[[@B1],[@B6]\]. Twenty-six to 46% of infected persons who develop meningo-encephalitis suffer from post-encephalitic sequelae \[[@B1]\]. No specific anti-viral therapy has been developed, but safe and effective vaccines are available \[[@B7]\]. Primary immunisation consisting of three doses followed by booster doses administered 3--5 years apart is sufficient to acquire immunity \[[@B7],[@B8]\]. Documentation of endemic foci allows development of focused vaccination recommendations \[[@B9],[@B10]\]. However, to locate endemic foci, physicians must be aware of the disease and refer patients with signs of meningo-encephalitis for testing.

Poland (2010 population: 38 million) is divided into 16 provinces and 379 districts. TBE surveillance was implemented in 1970. Physicians notify meningo-encephalitis cases, including confirmed TBE cases. Vaccination is recommended for persons occupationally exposed to forests in endemic districts (i.e. farmers, foresters, soldiers). However, employers or individuals have to cover the vaccine cost \[[@B9]\]. The location of endemic areas for those recommendations is ascertained based on TBE reported rates. However, in 2004--2008 availability of serological diagnosis in only 39% of the country's hospitals suggested that TBE remained undiagnosed in many provinces \[[@B11]\]. Furthermore, seroprevalence surveys among humans and animals suggested that TBE endemic foci existed in districts where no human cases had been reported \[[@B12],[@B13]\].

Between March 2009 and April 2010, we implemented a pilot project of enhanced surveillance for TBE in selected Polish provinces. We aimed at describing patterns of the physician's diagnosis, including referral for serological testing. In this paper, we summarize 13 months of enhanced TBE surveillance and assess the degree to which extension of serological testing to districts where it was not available led to identification of new endemic foci in Poland.

Methods
=======

We appointed epidemiologists that were delegated from the local and provincial health departments as local and provincial coordinators. Their role was to set up enhanced surveillance in selected wards admitting patients with aseptic meningo-encephalitis. Before the initiation of the project, we organized half-day training conferences for all project participants. The conferences covered lectures on tick-borne encephalitis and active surveillance methods.

Case definitions
----------------

We defined a suspect TBE case as a patient hospitalized in a participating ward during the study period whose admission ICD-10 code indicated aseptic meningo-encephalitis or whose specimen was sent to the National Reference Laboratory (NRL) for TBE confirmation. We defined a confirmed TBE case as a suspected case in which detection of antibodies in serum (IgM and IgG) and/or in the cerebrospinal fluid CSF (IgG) confirmed current TBEV infection.

Population under surveillance
-----------------------------

Due to logistical constraints, we selected 11 out of 16 Polish provinces, including some with and without known endemic foci. First, we defined the upper limit for the number of hospital wards that could be included considering the available budget. Second, we added provinces following approval of provincial chief medical officers, and included hospital wards identified by a prior survey as routinely notifying aseptic meningo-encephalitis cases during the previous 5 years \[[@B11]\]. In these hospitals, we offered physicians the opportunity to send serum and CSF specimens from suspected cases for free confirmatory testing in the NRL. The decision to send samples for testing was made by hospital physicians. Local coordinators screened hospital registers for suspect cases and reported them weekly to provincial coordinators. For each suspect case, local coordinators filled out routine surveillance forms that included demographic, clinical and epidemiological information assessing possible exposure to ticks at the site of residence and elsewhere. Provincial coordinators collected weekly lists of suspect cases, the information on the number of requested tests, and surveillance forms. They validated and forwarded them to the central coordination team.

Laboratory procedures
---------------------

Serum specimens were diluted 1:100 and tested for IgM and IgG anti-TBE antibodies. CSF specimens were diluted 1:10 and tested for IgG anti-TBE antibodies. We used an ELISA test (FSME/ESME ELISA IgG/IgM Testkit, Genzyme Diagnostics VIROTECH, Germany), according to the manufacturer's instructions. Results were expressed in "Vienna Units" (VE) defined as the ratio of absorbance (OD) of test specimen to the mean OD values of cut-off control, multiplied by 10. A specimen was considered positive if VE \>11, negative if \<9 and equivocal if 9 ≥ VE ≤11. Equivocal results were not considered for confirming cases. Specimens shipped to the laboratory were tested once or twice per week. Due to cross-reactivity with other flaviviruses pathogenic to humans, TBE ELISA positive results should by confirmed by more specific methods (ie., heamagglutination or neutralization tests) \[[@B1],[@B14]\]. This is not performed routinely in Poland due to high cost and lack of other neuroinvasive flaviviral infections detected in humans to date.

Data analysis
-------------

Choropleth maps were used to display the geographical location of TBE endemic districts, taking the Eurostat NUTS-4 administrative districts \[[@B15]\] as the unit of ascertainment. We calculated reported rates per 100,000 inhabitants by dividing the number of cases assigned to the presumed district of exposure by district mid-year census estimates. To account for uneven population density and uneven case clustering within the districts, we smoothed the maps of endemic districts by weighting reported rates of each district to the rates in adjacent districts. Using these established reported rates, we classified districts as non-endemic (\< 0.1 cases per 100,000 inhabitants), low endemic (\> = 0.1 to \< 1), moderately endemic (\> = 1 to \< 5) and highly endemic (\> = 5). We assigned urban districts (i.e., boundaries of larger towns) with the same endemicity status as the surrounding rural districts.

To assess the performance of enhanced surveillance, we calculated the proportion of TBE suspect cases, proportion of suspect cases referred for testing and proportion of positives, stratified by age group and 2004--2008 endemicity status of the district of hospital location.

We compared the endemicity status of districts in 2009 (using the data from a routine surveillance system that included additional cases identified through our project) with their status in 2004--2008 (using data from the routine surveillance system alone). We defined new endemic districts as those classified as non-endemic in 2004--2008, that were classified as endemic in 2009. We used STATA ver. 10 for data management and statistical analysis \[[@B16]\].

Human subjects protection
-------------------------

The study used existing surveillance data. The only deviation from routine surveillance procedures was facilitating serum and CSF specimen testing for TBE at the NRL and planned storage of leftover specimens in a biobank for further investigation of neuroinvasive pathogens. The local coordinators obtained informed consent from each patient tested. They returned test results to clinicians immediately. The Ethical Committee of the National Institute of Public Health -- National Institute of Health approved the enhanced surveillance protocol.

Results
=======

We implemented enhanced surveillance in 146 hospital wards during a median period of 11.2 months (mean 11.5 months, range: 7.2 to 14.2). Of 166,099 patients admitted to these wards, 1,585 were suspect cases \[mean age: 35.0 years, 841 of males (53%); Table [1](#T1){ref-type="table"}\]. Hospital wards included in enhanced surveillance represented 81% of wards hospitalizing meningo-encephalitis patients in the 11 provinces and 49% of all wards in Poland.

###### 

Characteristics of patients (n = 1,585) included as suspect tick-borne encephalitis cases, Poland, March 2009-April 2010

   **Characteristic**             **Number of patients**   **%**
  -------------------- --------- ------------------------ -------
      Age (years)         0-9              136              8.6
         10-19            325              20.5           
         20-29            305              19.2           
         30-39            222              14.0           
         40-49            184              11.6           
         50-59            193              12.2           
          60+             220              13.9           
          Sex            Male              841             53.1
         Female           744              46.9           
     Residence type      Rural             712             45.0
         Urban            869              55.0           
     Month of onset     January             57              3.6
        February          79               5.0            
        March\*           89               5.6            
        April\*           82               5.2            
          May             66               4.2            
          June            133              8.4            
          July            309              19.5           
         August           273              17.2           
       September          212              13.4           
        October           138              8.7            
        November          85               5.4            
        December          62               3.9            

\* Summed cases reported in March-April 2009 and March-April 2010.

Of 1,585 suspect cases reported, physicians referred 1,106 (70%) for testing, including 1,028 serum and 808 CSF specimens. TBEV infection was confirmed in 246 patients, 173 based only on serum antibody detection, 6 based only on CSF antibody detection, and 77 based on antibody detection in both serum and CSF.

Physicians reported 12 suspect cases per 1,000 admitted patients \<40 years old, of which 70% were tested (Table [2](#T2){ref-type="table"}). For the same period, physicians reported 7 suspect cases per 1,000 admitted patients ≥40 years old, of which 70% were tested (Table [2](#T2){ref-type="table"}). The proportion of patients that tested positive for TBE increased with age (Figure [1](#F1){ref-type="fig"}).

![Number of suspected cases tested and percent positive by age group, Poland, March 2009-April 2010.](1756-3305-6-180-1){#F1}

###### 

Selected surveillance indicators measured in the observed population, by endemic status hospital region, 146 hospital units, March 2009-April 2010

  **Characteristic**                               **Admissions**  **Suspect TBE cases**                              
  -------------------------------- ------------- ---------------- ----------------------- ----- ------- ------ ------ ------
  **Endemic status of hospital**   Non-endemic             89,309           639            7.2    378    59.2    17    4.5
  Low endemic                      61,093                     594           9.7            416   70.0     74    17.8  
  Moderately endemic               8,731                      135          15.5            117   86.7     32    27.4  
  Highly endemic                   6,966                      217          31.2            195   89.9    133    68.2  
  **Age (years)**                  0-9                     34,851           136            3.9    89     65.4    3     3.4
  10-19                            15,734                     325          20.7            254   78.2     34    13.4  
  20-29                            12,866                     305          23.7            209   68.5     39    18.7  
  30-39                            13,623                     222          16.3            137   61.7     34    24.8  
  40-49                            15,633                     184          11.8            143   77.7     49    34.3  
  50-59                            25,013                     193           7.7            142   73.6     53    37.3  
  60+                              48,379                     220           4.6            132   60.0     44    33.3  
  **Total**                                               166,099          1,585           9.5   1,106   69.8   256    23.2

*TBE* tick-borne encephalitis.

In hospitals located in districts classed as moderately and highly endemic in 2004--2008, physicians reported an average of 22 TBE suspected cases per 1000 hospitalized patients. Of those, 89% were tested for TBE. In hospitals located in districts classed as non-endemic and low endemic in 2004--2008, physicians reported 8 suspected cases per 1000 hospitalizations. Of those 64% were referred for testing (Table [2](#T2){ref-type="table"}).

In 2009, 351 TBE cases were reported in Poland (0.92 per 100,000 inhabitants), 51% more than the annual median number of 233 cases (average annual reported rate 0.61) in 2004--2008. The status of 291 districts did not change between the two periods (Table [3](#T3){ref-type="table"}). However, in 2009 we identified 38 new endemic districts. Of these, 31 were adjacent to known endemic foci in the Northeast and in the South and seven were isolated foci in the North and Centre of the country (Figure [2](#F2){ref-type="fig"}).

![Geographical distribution of TBE endemic districts, Poland; a) Provinces selected for active surveillance; b) Endemic districts classified based on average reported rates during 2004--2008; c) Endemic districts classified based on reported rates recorded during 2009; d) Location of the newly identified endemic districts.](1756-3305-6-180-2){#F2}

###### 

Districts whose TBE endemicity status changed between 2004--2008 and 2009

  **TBE endemic status of district**     **Number of districts in 2004-2008**  **Change of TBE endemic status in 2009**                        
  ------------------------------------ -------------------------------------- ------------------------------------------ ---------- ---------- -----------
  Non endemic                                                             239                 201 (84%)                   36 (15%)    2 (1%)       \-
  Low endemic                                                              95                  14 (15%)                   50 (53%)   31 (32%)      \-
  Moderately endemic                                                       17                     \-                      3 (18%)    12 (71%)    2 (11%)
  Highly endemic                                                           28                     \-                         \-         \-      28 (100%)
  All districts                                                           379                 215 (57%)                   89 (23%)   45 (12%)    30 (8%)

*TBE* tick-borne encephalitis.

Discussion
==========

In 2009, we identified 38 new endemic districts. These may reflect old endemic districts that were undetected until 2009. Testing for TBE in patients with signs of meningo-encephalitis doubled in the entire country in 2009, compared with the annual number of specimens processed in previous years \[[@B11]\]. Moreover, according to the 2008 survey of hospitals admitting patients with meningo-encephalitis \[[@B11]\], districts newly identified as TBE endemic previously lacked routine diagnosis. One should not rule out that newly identified foci could also reflect the spread of TBE risk to new foci. Seven of the new endemic districts were situated away from previously known endemic foci, most notably in the Northwest of the country (Figure [2](#F2){ref-type="fig"}d). The possible existence of undetected TBE foci in these areas is supported by earlier seroepidemiological investigations \[[@B13]\]. New TBE foci can emerge, as reported in Sweden, Denmark and Norway \[[@B17]-[@B21]\]. Evidence from other European countries indicates that foci are extending particularly to the north \[[@B1],[@B19],[@B22]\] and higher altitudes \[[@B1],[@B23]\]. These changes can be explained by complex interactions of environmental factors \[[@B3],[@B4],[@B18]\], changing patterns in climate and human behaviour, including travel, outdoor activities \[[@B18],[@B22]\] and socio-economic changes \[[@B24],[@B25]\]. For example, Godfrey and Randolph found a correlation between the 2009 high increases in TBE reported rates in Poland, Lithuania and Latvia and the high background levels of poverty \[[@B24]\].

Compared with endemic districts, referral for diagnosis was less common in districts that were non-endemic or low endemic in 2004--2008. According to the 2008 survey of hospitals admitting patients with meningo-encephalitis \[[@B11]\], physicians were reluctant to refer patients for TBE testing mostly due to the cost of serologic testing, considered as not justified by the available treatment options. However, our enhanced surveillance ensured availability of cost-free diagnosis in all participating wards. In addition, physicians in districts highly endemic in 2004--2008 referred patients with signs of meningo-encephalitis for testing 7-times more commonly than in districts considered non-endemic in 2004--2008. The decreased awareness of physicians in TBE-free districts may result in an underestimation of TBE outside known endemic areas. This might still leave possible endemic districts undetected.

Children and young adults were tested frequently, but few were positive for TBE. In contrast, older adults, including the elderly were rarely tested, yet a large proportion was positive. This may reflect the higher incidence of all cases of meningo-encephalitis diagnosis among children and adolescents. On the other hand, TBE leads to more severe disease in elderly patients, and is more difficult to diagnose because of atypical symptoms. This discrepancy between testing practices and age-specific risk may lead the Polish surveillance system to underestimate TBE reported rates.

This investigation had a number of limitations. First, 13-month enhanced surveillance may have been too short timeframe for reliable documentation of TBE foci. TBEV may circulate undetected for some time before the transmission to humans starts to occur, due to favourable weather conditions or socio-economic changes \[[@B24],[@B26]\]. Therefore, the detection of sporadic cases could result in ascertainment of least populated districts as low endemic. To minimize this phenomenon, we smoothed maps of endemic districts, as was previously carried out routinely in Germany \[[@B27]\]. Second, we cannot rule out the possibility that the appearance of new foci reflected a real 2009 TBE peak in Poland. This is supported by a concomitant high TBE increase recorded in the Baltic countries that was triggered by an economic downturn \[[@B24]\]. In Poland it would be difficult to disentangle the real increase caused by in-work risk of poverty \[[@B24]\] with the effect of the unlimited testing offered to physicians through our enhanced surveillance in many regions where testing was not carried out. Third, coverage limited to 49% of hospital wards and lower awareness of physicians working in non-endemic districts may have led to geographical differences in surveillance performance. Thus, absence of evidence of disease in our project cannot be interpreted as a documentation of absence of TBE risk in several non-endemic districts, particularly in those where too few specimens were tested. Finally, cross-reactivity of serological tests used to confirm TBE \[[@B1],[@B14]\] could theoretically have captured meningo-encephalitis cases caused by other flaviviruses. Thus, if other flavivirus were to be documented in Poland, laboratory diagnosis of TBE should be extended to neutralization testing.

Conclusions
===========

In conclusion, our enhanced surveillance enabled detection of new TBE endemic districts by offering systematic screening of all suspect TBE cases in a large proportion of Polish hospitals. However, lack of consistent testing in districts believed to be TBE-free remained an obstacle for mapping TBE risk. Although the disease is more severe in older adults and the elderly, more attention is given to the diagnosis of TBE in young patients. On the basis of these conclusions, we recommend (1) implementation of the national immunization policy in newly identified endemic districts; (2) uniform implementation of diagnostic procedures in all Polish hospitals and (3) more attention to diagnosis of TBE in the elderly.
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